IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 233 filers reported holding IMMUNOVANT INC in Q4 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10,245,840 | +93247.7% | 388,100 | +14.2% | 0.02% | 0.0% |
| Q1 2024 | $10,976 | +1323.6% | 339,700 | +1756.3% | 0.02% | +1600.0% |
| Q4 2023 | $771 | -90.9% | 18,300 | -91.7% | 0.00% | -92.9% |
| Q3 2023 | $8,500 | -4.2% | 221,400 | -52.7% | 0.01% | +7.7% |
| Q2 2023 | $8,874 | +16.3% | 467,800 | -4.9% | 0.01% | +30.0% |
| Q1 2023 | $7,633 | +25.0% | 492,112 | +43.0% | 0.01% | +25.0% |
| Q4 2022 | $6,108 | -99.7% | 344,100 | -2.4% | 0.01% | +166.7% |
| Q3 2022 | $1,967,000 | +51.7% | 352,500 | +6.0% | 0.00% | +50.0% |
| Q2 2022 | $1,297,000 | +133.7% | 332,600 | +230.3% | 0.00% | +100.0% |
| Q1 2022 | $555,000 | +270.0% | 100,700 | +472.2% | 0.00% | – |
| Q4 2021 | $150,000 | -42.1% | 17,600 | +214.3% | 0.00% | – |
| Q4 2020 | $259,000 | -70.7% | 5,600 | -84.6% | 0.00% | -100.0% |
| Q2 2020 | $884,000 | – | 36,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 3,000,200 | $26,072,000 | 5.92% |
| MANGROVE PARTNERS IM, LLC | 1,139,900 | $9,906,000 | 0.89% |
| Eventide Asset Management | 4,950,000 | $43,016,000 | 0.57% |
| Ghost Tree Capital, LLC | 200,000 | $1,738,000 | 0.51% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,221,000 | 0.47% |
| FRAZIER MANAGEMENT LLC | 585,759 | $5,090,000 | 0.41% |
| MANGROVE PARTNERS IM, LLC | 500,000 | $4,345,000 | 0.39% |
| EcoR1 Capital, LLC | 1,140,819 | $9,914,000 | 0.34% |
| BCK CAPITAL MANAGEMENT LP | 53,459 | $465,000 | 0.28% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 555,065 | $4,824,000 | 0.14% |